Thank you, Dr. Greaves.
I'd like to thank our witnesses for being with us here today. The depth of their experience and expertise is very clear, and the information they provided will undoubtedly be valuable to us as we start to put together some recommendations from here, going forward.
Thank you for taking the time and for being so patient and thorough in your answers.
I have two items before we adjourn.
Colleagues, later today, we will receive documents from witnesses who appeared for the study of the Patented Medicine Prices Review Board. These will need to be translated, so there will be a delay. We will ask the translation bureau to prioritize this request so that we have it back as soon as possible.
On another note, it is with some regret that I have to inform you our illustrious analyst Sarah Dodsworth is going to be leaving us. She's not going far, but she will no longer be attending committee meetings and providing the excellent service we have enjoyed during her tenure. I'm sure you'll join me in wishing her all the best in her new responsibilities within the Library of Parliament.